[11] [12] The primary mechanism of action involves binding to GLP-1 receptors located throughout the body, particularly in pancreatic beta cells, the gastrointestinal tract, and the central nervous system
The study of more than 111,000 women found that those who took popular GLP-1 drugs prescribed for obesity or diabetes had a more than 30% lower risk of breast cancer, though the researchers cautioned that the observational study doesnt prove the popular weight-loss drugs reduce cancer risk
Several of those letters specifically named retatrutide
For example, in June 2025, Connecticut Attorney General released a statement warning businesses of allegedly or potentially unfair and deceptive conduct related to compounding of GLP-1 medications
If you think a medicine may be affecting your weight, discuss this with your GP or clinical pharmacist do not stop any prescribed medicine without medical advice